An analysis of the predictive probability of the in vitro contracture test for determining susceptibility to malignant hyperthermia

Anesthesia and Analgesia

Volumn 84, Issue 3, 1997, Pages 648-656

  Hopkins, Philip M ^a   Ellis, F Richard ^a   Halsall, P Jane ^a   Stewart, Alistair D ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; HALOTHANE; RYANODINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENETIC LINKAGE; HISTOGRAM; HUMAN; MAJOR CLINICAL STUDY; MALIGNANT HYPERTHERMIA; PREDICTION; PRIORITY JOURNAL; PROBABILITY; RECEIVER OPERATING CHARACTERISTIC; REGRESSION ANALYSIS; REPRODUCIBILITY;

ADOLESCENT; ADULT; AGED; BIOPSY; CAFFEINE; CHILD; CONTRACTURE; DISEASE SUSCEPTIBILITY; HALOTHANE; HUMANS; MALIGNANT HYPERTHERMIA; MIDDLE AGED; PROBABILITY; REGRESSION ANALYSIS; RYANODINE;

EID: 0031058126     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199703000-00034     Document Type: Article

References (11)

1. Kalow W, Britt BA, Terreau ME, Haist C. Metabolic error of muscle metabolism after recovery from malignant hyperthermia. Lancet 1970;2:895-8.
2. Ellis FR, Keaney NP, Harriman DGF, et al. Screening for malignant hyperthermia. BMJ 1972;3:559-61.
3. European Malignant Hyperpyrexia Group. A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. Br J Anaesth 1984;56:1267-9,
4. European Malignant Hyperthermia Group. Laboratory diagnosis of malignant hyperthermia susceptibility (MHS) [letter]. Br J Anaesth 1985;57:1038.
5. Hopkins PM, Halsall PJ, Ellis FR. Diagnosing malignant hyperthermia susceptibility. Anaesthesia 1994;49:373-5.
6. Hopkins PM, Ellis FR, Halsall PJ. Ryanodine contracture: a potentially specific in vitro diagnostic test for malignant hyperthermia. Br J Anaesth 1991;66:611-3.
7. Hopkins PM, Ellis FR, Halsall PJ. Comparison of in vitro contracture testing with halothane, caffeine and ryanodine in patients with malignant hyperthermia and other neuromuscular disorders. Br J Anaesth 1993;70:397-401.
8. Ellis FR, Halsall PJ, Christian AS. Clinical presentation of suspected malignant hyperthermia during anaesthesia in 402 probands. Anaesthesia 1990;45:838-41.
9. Larach MG, Landis JR, Bunn JS, et al. Prediction of malignant hyperthermia susceptibility in low-risk subjects. Anesthesiology 1992;76:16-27.
10. Bland M. An introduction to medical statistics. 2nd ed. Oxford: Oxford University Press, 1995:306-30.
11. Hauck WW, Donner A. Wald's test as applied to hypotheses in logit analysis. J Am Stat Assoc 1977;72:851-3.